NCT02175784View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

December 7, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ipragliflozin

oral

DRUG

placebo

oral

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kanto

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY